ANL - Utang jangka cendhak marang modal Adlai Nortye Limited
This price chart on GURU.Markets for Adlai Nortye Ltd. (ANL) demonstrates the 0.07 metric. Adlai Nortye Ltd. is a biopharmaceutical firm developing oncology drugs with global sales potential and high margins following patent approval. The company minimizes risks by distributing its research centers across Europe, China, and the US. Supply chain efficiency is ensured through flexible management of regional hubs and precise raw material procurement planning.
Rincian metrik keuangan lan pasar Adlai Nortye Limited (ANL)
- nilai saham lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Rasio Total Utang marang Ekuitas Adlai Nortye Ltd.|ANL - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Adlai Nortye Ltd.|ANL - Gunggung utang perusahaan|Utang marang nilai buku Adlai Nortye Ltd|ANL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Adlai Nortye|Rasio cepet adlainortye.com
- statistik bathi lan rasio pasar:
Analisis fundamental perusahaan:Adlai Nortye ANL
For Adlai Nortye Ltd. (ANL), which maneuvers between US and PRC regulators, the structure of short-term liabilities relative to capital serves as an indicator of financial resilience to geopolitical shocks. This metric measures the proportion of loans with a maturity of over one year relative to equity, allowing for an assessment of the business's ability to withstand peak loads and balance excessive caution with the efficient use of borrowed funds.
Analisis perusahaan pesaing
Utang jangka cendhak marang ekuitas BeiGene Corp (ONC)|Halozyme Corp - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal RVMD (Revolution Medicines)|AAPG - Rasio utang jangka cendhak marang ekuitas|CG Oncology - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal UroGen Pharma Ltd|Bicara Bio (BCAX) - Utang jangka cendhak marang ekuitas|Personalis Genomics - Rasio tanggungan utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas ERAS|DCTH: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal YMAB|Rasio utang jangka cendhak marang ekuitas Aura Biosciences Inc AURA|Candel Therapeutics, Inc. - Rasio utang jangka cendhak marang ekuitas|Utang jangka cendhak marang modal Accuray, Inc. ARAY|SLS - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal ACTU (actuatetherapeutics.com)|CTOR: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal TuHURA Biosciences (HURA)|TARA (Protara) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal Fate Pharma|Utang jangka cendhak marang modal WHWK|tscan.com - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Champions Oncology, Inc. CSBR|XBiotech Inc - Utang jangka cendhak marang ekuitas|CEL-SCI Corp - Utang jangka cendhak marang modal|OSTX - Utang jangka cendhak marang modal|RADX: Utang jangka cendhak marang modal|ARTV - Koefisien utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas VERU|TPST: Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Xilio Therapeutics, Inc. (XLO)|renovarobio.com - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Mural Oncology MURA|Kairos Pharma Limited (KAPA) - Kewajiban jangka cendhak marang modal|OKUR - Utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal GDTC (CytoMed Therapeutics)|CRIS (curis.com) - Rasio utang jangka cendhak marang ekuitas|APLM: Rasio silihan jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas THAR|Kewajiban jangka cendhak marang modal Advanced Biomed Corp ADVB|Utang jangka cendhak marang modal GNPX|CLDI - Kewajiban jangka cendhak marang modal|Sunshine Biopharma - Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal XBIO|SLRX - Utang jangka cendhak marang ekuitas|PPBT: Utang jangka cendhak marang ekuitas|AONC (aoncology.com) - Rasio utang jangka cendhak marang ekuitas|BGNE: Rasio silihan jangka cendhak marang modal|CKPT (Checkpoint Therapeutics, Inc) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang modal ELEV (Elevation Oncology Inc.)|Rasio utang jangka cendhak marang ekuitas ICAD (iCAD, Inc.)|Koefisien utang jangka cendhak marang modal ikenaoncology.com|Utang jangka cendhak marang modal NTBL (Notable Labs)|Utang jangka cendhak marang modal Viracta Therapeutics Inc. VIRX|MOR - Utang jangka cendhak marang ekuitas|NAYA (NAYA Biosciences Corp) - Rasio utang jangka cendhak marang modal|Ascentage Pharma Group (AAPGV) - Utang jangka cendhak marang ekuitas